Impact of Graft Versus Host Disease Prophylaxis with Post Transplant Cyclophosphamide on the Prognostic Value of HCT-CI

Key Points

• Graft versus host disease prophylaxis improves prognostic value for HCT-CI scores, enhancing patient outcomes.
• A significant finding indicates outcomes linked to cyclophosphamide treatment, with p-values confirming efficacy.
• Observational analysis across various patient populations highlights the importance of prophylactic measures.
• These results support enhanced strategies for managing graft versus host disease, requiring further large-scale studies.